These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 13923624)

  • 1. [Hemagglutination in Behcet's disease and other diseases. Its significance in diagnosis].
    UJIHARA S; KOGURE M
    Rinsho Ganka; 1962 Mar; 16():305-8. PubMed ID: 13923624
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on fibrinolytic activity in Behçet's disease. II. Fibrin degradation product].
    Saito K
    Nippon Ganka Gakkai Zasshi; 1973 Jul; 77(7):693-8. PubMed ID: 4738794
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum prolactin levels in Behçet's disease. Is there a relationship between Behcet's disease and prolactin as in other autoimmune diseases?
    Avci A; Avci D
    Acta Dermatovenerol Croat; 2013; 21(1):52-3. PubMed ID: 23683488
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunological studies on Behçet's syndrome.
    Shimizu T; Katsuta Y; Oshima Y
    Ann Rheum Dis; 1965 Sep; 24(5):494-500. PubMed ID: 4158024
    [No Abstract]   [Full Text] [Related]  

  • 5. [Autoimmunity in Behcet's syndrome].
    Oshima Y
    Nihon Rinsho; 1968 Apr; 26(4):1020-4. PubMed ID: 4176476
    [No Abstract]   [Full Text] [Related]  

  • 6. [Mycoplasma antibody in Behçet's disease].
    Kunishi M
    Nihon Ganka Kiyo; 1967 Aug; 18(8):830-40. PubMed ID: 5626006
    [No Abstract]   [Full Text] [Related]  

  • 7. [Plasma coagulation and fibrinolysis parameters in patients with vascular Behçet's disease, and analysis of the multimeric structure of von Willebrand factor (vWF)].
    Kagawa H; Okubo S
    Ryumachi; 1993 Oct; 33(5):416-23. PubMed ID: 8256164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum interleukin 18 and tumour necrosis factor-alpha levels are increased in Behcet's disease.
    Oztas MO; Onder M; Gurer MA; Bukan N; Sancak B
    Clin Exp Dermatol; 2005 Jan; 30(1):61-3. PubMed ID: 15663506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma-soluble urokinase plasminogen activator receptor (suPAR) levels in Behçet's disease and correlation with disease activity.
    Saylam Kurtipek G; Kesli R; Tuncez Akyurek F; Akyurek F; Ataseven A; Terzi Y
    Int J Rheum Dis; 2018 Apr; 21(4):866-870. PubMed ID: 27171829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum leptin levels in patients with ocular and nonocular Behçet's disease.
    Yalçindağ FN; Kisa U; Batioğlu F; Yalçindağ A; Ozdemir O; Cağlayan O
    Mediators Inflamm; 2007; 2007():31986. PubMed ID: 17641728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of leptin level and Ob gene polymorphism in patients with Behcet's disease.
    Okudan N; Acar H; Gökbel H; Mevlitoğlu I; Sari F
    Arch Dermatol Res; 2006 Aug; 298(3):127-30. PubMed ID: 16786343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do hemorheological alterations play any role in the development of thrombotic events in Behçet's disease?
    Vayá A; Ricart J; Todolí J; Micó L; Contreras T; Aznar J
    Clin Hemorheol Microcirc; 2004; 30(3-4):411-4. PubMed ID: 15258375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of the arterial intima-media thickness in Behcet's disease patients without vascular complaints.
    Kankilic N; Aslan A; Karahan O; Demirtas S; Caliskan A; Yavuz C
    Vascular; 2018 Aug; 26(4):356-361. PubMed ID: 29182089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pathophysiological significance of red blood cell nitric oxide concentrations in inflammatory Behçet's disease.
    Evereklioglu C; Cekmen M; Ozkiriş A; Karabaş L; Caliş M
    Mediators Inflamm; 2003 Aug; 12(4):255-6. PubMed ID: 14514478
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunohematological studies on Behçet's disease. Histocompatibility (HL-A) antigens and I blood group system (author's transl)].
    Ono S; Aoki K; Sugiura S; Nakayama E; Itakura K
    Nippon Ganka Gakkai Zasshi; 1973 Sep; 77(9):1452-60. PubMed ID: 4797116
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparison between the effects of low (1 microg) and standard dose (250 microg) ACTH stimulation tests on adrenal cortex functions with Behçet's disease.
    Colak R; Ozkan Y; Cengiz SU; Saral Y; Kandi BC; Halifeoglu I
    J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):721-5. PubMed ID: 16836503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between serum prolactin levels and disease activity in patients with Behcet's disease.
    Atasoy M; Karatay S; Yildirim K; Kadi M; Erdem T; Senel K
    Cell Biochem Funct; 2006; 24(4):353-6. PubMed ID: 15898123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of homocysteine, neopterin and nitric oxide levels in Behçet's disease.
    Ozkan Y; Yardim-Akaydin S; Sepici A; Engin B; Sepici V; Simşek B
    Clin Chem Lab Med; 2007; 45(1):73-7. PubMed ID: 17243919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical treatment of Budd-Chiari syndrome induced by Behcet's disease.
    Kuniyoshi Y; Koja K; Miyagi K; Uezu T; Yamashiro S; Arakaki K; Mabuni K; Senaha S
    Ann Thorac Cardiovasc Surg; 2002 Dec; 8(6):374-80. PubMed ID: 12517299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormalities of T-cell subsets in Behçet's syndrome.
    Lim SD; Haw CR; Kim NI; Fusaro RM
    Arch Dermatol; 1983 Apr; 119(4):307-10. PubMed ID: 6220679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.